Skyscape Web Viewer : TNM Cancer Staging Manual : Main Index

View All
Chromosomal microarray
Chronic lymphocytic leukemia (CLL) CIRS del(11q)/ATM mutation Leukemia: Chronic Myeloid clinical classification IGHV mutation status MBL
Chronic myeloid leukemia (CML) clinical classification prognostic factors laboratory features risk assessment models
Chronic open angle glaucoma (COAG), management of
Ciliary body melanoma Kaplan-Meier stage-specific estimates clinical classification primary tumor (T)
CIN
Circulating tumor cells (CTCs)
Cisplatin Adrenal Cortical Carcinoma Renal Pelvis and Ureter: Urothelial Carcinomas Urinary Bladder: Urothelial Carcinomas Renal Pelvis and Ureter: Squamous Cell Carcinoma and Adenocarcinoma Urinary Bladder: Squamous Cell Carcinoma and Adenocarcinoma
CKD-MBDs
Classification of NPC
Clear cell tumors Corpus Uteri: Carcinoma and Carcinosarcoma Ovary, Fallopian Tube, and Primary Peritoneal Carcinoma
Clinical criteria to categorize a lesion as a separate tumor nodule (intrapulmonary metastasis)
Clinical criteria to categorize a tumor as pneumonic-type adenocarcinoma
Clinical features of functional pancreatic neuroendocrine tumors
Clinical Laboratory Improvement Amendments (CLIA) Neuroendocrine Tumors of the Appendix Neuroendocrine Tumors of the Duodenum and Ampulla of Vater Neuroendocrine Tumors of the Stomach Neuroendocrine Tumors of the Colon and Rectum Neuroendocrine Tumors of the Jejunum and Ileum
Clinical mapping system for conjunctival melanoma
Clinical N3 is defined as palpable fixed inguinal nodal mass or pelvic lymphadenopathy unilateral or bilateral
Clinical stage and 1-, 3-, and 5-year and median overall survivals in patients diagnosed with gastric cancer, stratified by clinical stage groupings, based on NCDB data
Clinical stage and overall survival in patients with gastric cancer who received curative or palliative surgery, stratified by clinical stage groupings, based on Shizuoka Cancer Center data (2002-2015; median follow-up, 47 months; n = 4,091)
CML
College of American Pathology (CAP) Introduction and Overview Neuroendocrine Tumors of the Jejunum and Ileum Neuroendocrine Tumors of the Colon and Rectum Neuroendocrine Tumors of the Stomach
Colon and rectal carcinoma
Colony-stimulating factor Plasma Cell Myeloma Other Plasma Cell Disorders
Combination therapy, for benign prostatic hyperplasia (BPH)
Cancer of the Liver Italian Program (CLIP)
Carcinoid syndrome
Carcinomas
CEA
Cell of origin (COO)
Central venous catheter (CVC)

NDX